
Eris Lifesciences Ltd
NSE:ERIS

Cash Flow Statement
Cash Flow Statement
Eris Lifesciences Ltd
Mar-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Net Income |
3 314
|
3 945
|
6 424
|
4 422
|
4 165
|
4 046
|
4 212
|
4 312
|
4 369
|
|
Depreciation & Amortization |
503
|
430
|
295
|
647
|
873
|
1 171
|
1 480
|
1 826
|
2 560
|
|
Other Non-Cash Items |
(60)
|
11
|
(97)
|
(155)
|
50
|
228
|
437
|
717
|
1 604
|
|
Cash Taxes Paid |
518
|
685
|
585
|
833
|
792
|
772
|
802
|
1 008
|
1 091
|
|
Cash Interest Paid |
18
|
18
|
18
|
39
|
152
|
234
|
458
|
773
|
1 105
|
|
Change in Working Capital |
(1 045)
|
(632)
|
(815)
|
(1 132)
|
(2 245)
|
(2 453)
|
(1 608)
|
(1 725)
|
(1 196)
|
|
Cash from Operating Activities |
2 711
N/A
|
3 754
+38%
|
5 807
+55%
|
3 783
-35%
|
2 844
-25%
|
2 992
+5%
|
4 521
+51%
|
5 130
+13%
|
7 338
+43%
|
|
Investing Cash Flow | ||||||||||
Capital Expenditures |
(1 513)
|
(258)
|
(180)
|
(1 210)
|
(2 424)
|
(8 414)
|
(7 748)
|
(1 292)
|
(1 137)
|
|
Other Items |
2 746
|
(2 976)
|
(4 176)
|
(1 986)
|
(1 572)
|
(1 407)
|
(704)
|
(17 254)
|
(17 679)
|
|
Cash from Investing Activities |
1 233
N/A
|
(3 234)
N/A
|
(4 356)
-35%
|
(3 196)
+27%
|
(3 997)
-25%
|
(9 821)
-146%
|
(8 452)
+14%
|
(18 545)
-119%
|
(18 816)
-1%
|
|
Financing Cash Flow | ||||||||||
Net Issuance of Common Stock |
(1 000)
|
0
|
58
|
67
|
33
|
23
|
16
|
45
|
69
|
|
Net Issuance of Debt |
(1 841)
|
(59)
|
(96)
|
335
|
2 442
|
8 091
|
5 600
|
14 628
|
14 662
|
|
Cash Paid for Dividends |
(470)
|
(747)
|
(817)
|
(816)
|
(999)
|
(999)
|
0
|
0
|
0
|
|
Other |
(35)
|
(18)
|
(842)
|
(33)
|
(147)
|
(234)
|
(561)
|
(876)
|
(3 480)
|
|
Cash from Financing Activities |
(3 346)
N/A
|
(824)
+75%
|
(1 697)
-106%
|
(447)
+74%
|
1 329
N/A
|
6 880
+418%
|
5 056
-27%
|
13 798
+173%
|
11 251
-18%
|
|
Change in Cash | ||||||||||
Net Change in Cash |
598
N/A
|
(304)
N/A
|
(246)
+19%
|
140
N/A
|
176
+26%
|
52
-71%
|
1 125
+2 083%
|
382
-66%
|
(227)
N/A
|
|
Free Cash Flow | ||||||||||
Free Cash Flow |
1 198
N/A
|
3 496
+192%
|
5 627
+61%
|
2 572
-54%
|
419
-84%
|
(5 422)
N/A
|
(3 227)
+40%
|
3 838
N/A
|
6 201
+62%
|